OmniSeq, an innovation of Roswell Park Cancer Institute, is a molecular diagnostic laboratory based in Buffalo, New York. OmniSeq endeavors to find the right drug or the right trial for every patient by improving access to better cancer treatment options through molecular profiling.
In addition to other NY State CLEP approved assays, OmniSeq offers OmniSeq Comprehensive and Immune Report Card. These two assays are available clinically in the United States and interrogate all known genomic and immune markers tied to approved therapeutics and clinical trials. OmniSeq is also making significant investments to create better diagnostics for immuno-oncology therapy selection. OmniSeq is proud to partner with pharmaceutical companies to provide research support for immuno-oncology development projects.
For more information, call 1-800-781-1259 or visit www.omniseq.com.
Company Details
- Employees
- 25
- Founded
- -
- Address
- 700 Ellicott Street, Buffalo,new York 14203,united States
- Phone
- 1(800)781-1259
- fi****@****seq.com
- Industry
- Biotechnology
- Website
- omniseq.com
- Keywords
- Cancer Genomics, Bioinformatics, Precision Medicine, clinical decision support, Oncology, Molecular Testing, Clinical Trial Access.
- HQ
- Buffalo, New York
Omniseq Questions
Omniseq's helpline number is 1(800)781-1259
Omniseq's website is omniseq.com
Omniseq's LinkedIn profile is https://www.linkedin.com/company/omniseq-precision-medicine-technology
Omniseq has
25 employees.
View email and phone details for 25
employees at Omniseq.
Omniseq's industry is
Biotechnology
Omniseq's top competitors are
Genecast Biotechnology Co., Ltd.,
Medgenome,
Corza Health,
Invitae,
Salus Biomed,
Illumina,
Quest Diagnostics,
Roswell Park Comprehensive Cancer Center,
Genemind Biosciences,
Labcorp.
Omniseq's support email address is firstname.lastname@omniseq.com
Omniseq's categories are Biotechnology
Omniseq's founding year is 2015
